Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0605
D

Failure to Ensure Unnecessary Psychotropic Drug Use Was Prevented

Barrigada, GU Survey Completed on 08-22-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to ensure that a resident was free from unnecessary psychotropic drug use. A resident with dementia was prescribed quetiapine, an antipsychotic medication, which was increased from 12.5 mg to 25 mg at bedtime despite no documented behavioral changes or rationale for the increase. Staff documentation and behavior monitoring forms showed no evidence of confusion or agitation from the time of the dose increase through the present. The neurologist's consultation and subsequent medication order did not include documentation of behaviors warranting the dose increase, and the facility's monitoring process did not prompt a review or discussion regarding the absence of behaviors. Interviews with nursing staff, the consultant pharmacist, and the Director of Nursing revealed a lack of awareness and action regarding the requirement for a gradual dose reduction (GDR) for psychotropic medications. The consultant pharmacist continued to document the same assessment and plan for the medication each month, without addressing the absence of behaviors or the need for a GDR. The facility did not have a policy specific to GDR for psychotropic medications, and staff did not provide a rationale for not attempting a dose reduction, despite regular interdisciplinary team meetings to discuss psychotropic medication use.

An unhandled error has occurred. Reload 🗙